Inventaire - your friends and communities are your best library

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

Author

Giorgio Walter Canonica

1947 -

Stephen R Durham

1952 -

Published in: Allergy

Date of publication: February 1, 2000

Main subject: immunology

Bibliographic databases:

Cites articles 123

Date

Title

Authors

July 1, 1913

The Present State of our Knowledge of Hay-Fever: Being a Paper Presented at the Berlin Congress of the Royal Institute of Public Health
April 1, 1973

The parasympathetic secretory nerves of the nose of the cat.
November 1, 1973

Local effect of intranasal beclomethasone dipropionate aerosol in hay fever,Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay Fever
December 1, 1979

Intranasal ipratropium: A new treatment for perennial rhinitis
August 1, 1983

Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients
August 1, 1983

Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. An open follow-up study of efficacy and safety
September 1, 1984

Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever
November 1, 1984

Nasal septal perforation associated with topical corticosteroid therapy
January 1, 1985

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy
May 1, 1985

Reduction of house dust mite allergen levels in the home: use of the acaricide, pirimiphos methyl
January 1, 1985

Treatment of perennial secretory rhinitis
March 1, 1986

Vascular effects of topical oxymetazoline on human nasal mucosa
December 1, 1987

Dust mites: immunology, allergic disease, and environmental control
January 1, 1987

Seasonal allergic rhinitis and depot injection of a corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording
April 1, 1987

Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients
November 1, 1987

Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease
April 1, 1987

Ordinary and high-dose ipratropium in perennial nonallergic rhinitis
September 1, 1987

Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide
April 1, 1987

Fatalities from immunotherapy (IT) and skin testing (ST)
November 1, 1989

Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
September 1, 1989

Nasal mucosal response to repeated challenges with pollen allergen
July 1, 1989

The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma
January 1, 1990

Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established
November 1, 1990

Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria
April 1, 1990

Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate
February 1, 1990

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract
August 1, 1990

A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology
January 1, 1990

Allergen-induced changes in the nasal mucous membrane in seasonal allergic rhinitis: effect of nedocromil sodium
February 1990

Long-term safety and efficacy study of intranasal ipratropium bromide
December 1, 1991

Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history
June 1, 1991

Airborne cat allergen (Fel d I). Environmental control with the cat in situ
May 1, 1991

The nasal allergic reaction: observations on the role of histamine

Article -

Welcome to inventaire

The library of your friends and communities

Learn more